Rheumatoid arthritis: vizsgálatok itt: Spanyolország
28 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study of AZD0120 in Autoimmune Diseases
- Where
- Barcelona, Madrid
- Életkor
- 18 év to 75 év
- People
- 27 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07295847 - 4. fázisTaking peopleCarotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
- Where
- Barcelona, Bilbao, Ciudad Real, Córdoba, Elche, Las Palmas De Gran Canaria, Madrid, Murcia, Orihuela, Palma, San Cristóbal de La Laguna, Santander, Sant Joan d'Alacant, Torrelavega, Vitoria, Hospital laredo
- Életkor
- 50 év and over
- People
- 1944
- Run by
- Instituto de Investigación Marqués de Valdecilla
See details and how to joinNCT07611747 · EU 2025-521086-28-00 - 1. fázisTaking peopleA Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
- Where
- Madrid, Pamplona, Santiago de Compostela
- Életkor
- 18 év to 75 év
- People
- 21 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07363590 · EU 2025-523412-36-00 - 1. fázisTaking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Barcelona, Córdoba, Madrid
- Életkor
- 18 év to 65 év
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - 1/2. fázisTaking peopleA Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
- Where
- A Coruña, Córdoba
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07412704 · EU 2025-520666-22-00 - 1. fázisTaking peopleA Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Where
- Mérida, Sevilla, Valladolid
- Életkor
- 18 év to 70 év
- People
- 72 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06916806 · EU 2024-519015-34-00 - 1/2. fázisTaking peopleControlling Hyperactive Immunity With Long-lived Lymphocytes
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 16 worldwide
- Run by
- Quell Therapeutics Limited
See details and how to joinNCT07473154 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Where
- La Corua, Málaga, Santiago de Compostela, Seville
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07137598 - 2. fázisTaking peopleAn Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
- Where
- A Coruña, Barcelona, Córdoba, Madrid, Málaga, Santiago de Compostela, Sevilla
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07620392 · EU 2025-523579-47-00 - 1/2. fázisTaking peopleStudy QEL-005-CLN-01. Phase I/II study of QEL-005 in patients with diffuse cutaneous systemic sclerosis (dcSSc) and in patients with difficult to treat rheumatoid arthritis (D2TRA).
- Where
- Madrid
- Életkor
- 18 év and over
- People
- 8 worldwide
- Run by
- Quell Therapeutics Limited
See details and how to join2025-523971-46-00 · EU 2025-523971-46-00 - 2. fázisTaking peopleA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Where
- Barcelona, Málaga, Sabadell, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07276581 - 2. fázisTaking peopleA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Where
- A Coruña, Bilbao, Córdoba, Madrid, Sabadell, Santander, Sevilla, Valencia
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- AbbVie
See details and how to joinNCT06972446 · EU 2025-520721-21-00 - 2. fázisTaking peopleA study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.
- Where
- Barcelona, Málaga, Sabadell, Santiago de Compostela, Valencia
- Életkor
- 18 év and over
- People
- 97 worldwide
- Run by
- AstraZeneca AB
See details and how to join2025-522076-85-00 · EU 2025-522076-85-00 - 2. fázisTaking peopleA Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Where
- Barcelona, Madrid, Santander
- Életkor
- 18 év to 75 év
- People
- 220 worldwide
- Run by
- Amgen
See details and how to joinNCT06570798 - 2. fázisNot yet taking people in SpanyolországA study to assess the safety and efficacy of different doses of ELV001 to treat active rheumatoid arthritis in patients with an inadequate response to methotrexate and tumor necrosis factor inhibition (START SYNERGY)
- Where
- Barcelona, Bilbao, Lugo, Madrid
- Életkor
- 18 év and over
- People
- 95 worldwide
- Run by
- Elevara Medicines Limited
See details and how to join2025-524005-32-00 · EU 2025-524005-32-00 - No phaseTaking peopleVantage Mobile Bearing Total Ankle System Post Market Clinical Follow-up (Outside US)
- Where
- Santa Cruz de Tenerife
- Életkor
- 21 év and over
- People
- 400 worldwide
- Run by
- Exactech
See details and how to joinNCT05691868 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
- Where
- A Coruña, Barcelona, Córdoba, Madrid, Málaga, Santiago de Compostela, Sevilla
- Életkor
- 18 év and over
- People
- 89 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2025-521034-28-00 · EU 2025-521034-28-00 - 4. fázisTaking people3TR-PARTNER-RA
- Where
- Barcelona, Córdoba
- Életkor
- 18 év and over
- People
- 182 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2024-511470-79-00 · EU 2024-511470-79-00 - 1. fázisTaking peopleA Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
- Where
- Córdoba, Sabadell, Sevilla
- Életkor
- 18 év and over
- People
- 19 worldwide
- Run by
- AbbVie Deutschland GmbH & Co. KG
See details and how to join2025-523127-21-00 · EU 2025-523127-21-00 - No phaseTaking peopleOxidative Stress and Cardiovascular Risk in Patients With Rheumatoid Arthritis
- Where
- Santa Cruz de Tenerife
- Életkor
- 18 év and over
- People
- 200
- Run by
- University of La Laguna
See details and how to joinNCT07760662 - 4. fázisTaking peopleThe 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
- Where
- A Coruna, Barcelona, Córdoba
- Életkor
- 18 év and over
- People
- 197 worldwide
- Run by
- Queen Mary University Of London
See details and how to join2022-502021-18-00 · EU 2022-502021-18-00 - 2. fázisTaking peopleAlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Where
- Sevilla
- Életkor
- 18 év and over
- People
- 90 worldwide
- Run by
- Artiva Biotherapeutics, Inc.
See details and how to joinNCT06991114 · EU 2025-520461-41-00 - 2. fázisNot yet taking people in SpanyolországTesting the safety and efficacy of combining biologic drugs in Rheumatoid and Psoriatic Arthritis
- Where
- Badalona, Barcelona
- Életkor
- 18 év and over
- People
- 10
- Run by
- Cardiff University
See details and how to join2024-518011-19-01 · EU 2024-518011-19-01 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Barcelona, Madrid
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - No phaseTaking peopleMedical Device for Sustained Remission in Rheumatoid Arthritis Treated With Biological Therapy
- Where
- A Coruña, Alava, Barcelona, Madrid, Málaga, San Cristóbal de La Laguna
- Életkor
- 18 év and over
- People
- 184
- Run by
- Francisco J. Blanco
See details and how to joinNCT07678112